[1]
2022. Assessment of HER2/neu among Female with Invasive Ductal Breast Carcinoma, Using Manual Tissue Microarray Technology in Khartoum State, Sudan. European Journal of Biomedical Research. 1, 4 (Aug. 2022), 10–13. DOI:https://doi.org/10.24018/ejbiomed.2022.1.4.20.